Navigation Links
Ventria Expands Lactoferrin Production
Date:10/17/2008

Lactoferrin expansion required to meet increasing global demand in infant formula and infant nutrition.

Junction City, KS (PRWEB) October 17, 2008 -- Ventria Bioscience announced it has successfully increased production of lactoferrin. Lactoferrin is a protein that is found naturally in breastmilk and has been credited with improved health benefits for breastfed children. It is used worldwide in infant formula and other functional foods. Ventria produces its lactoferrin by extracting the protein from rice produced by Kansas farmers.

"Expansion of our lactoferrin production allows us to meet the increasing demand for this important nutrient which is used globally in infant formula and other infant nutrition products," said Greg Unruh, General Manager. "We now have production to deliver thousands of kilograms of lactoferrin."

About Ventria Bioscience
Ventria Bioscience develops and markets health and nutrition products using its protein production system called ExpressTec. This technology has made it possible to cost-effectively deliver protein-based functional ingredients to the global community. Its first two products are proteins that are found naturally in breastmilk and have been shown to have benefits for use in infant formula and other infant nutrition products.

For more information, see our website at Ventria Bioscience
http://www.ventria.com

Or contact:
Erik Vogel, Communications Director

Statements in this announcement other than historical data and information constitute forward looking statements that involve risks and uncertainties that could cause actual results to differ materially from those stated or implied by such forward-looking statements. Potential risks and uncertainties may include, but are not limited to, recent changes in senior management, fluctuations in operating results, market conditions and changes in technology and increased competition.

###

Read the full story at http://www.prweb.com/releases/2008/10/prweb1485124.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related biology technology :

1. Ventria Expands Lactoferrin Production
2. Ventria Receives Friends of Education Award From Geary County School District
3. Ventria Expands Team and Hires Kansan as Director of Bioprocessing Operations
4. Science Teachers Tour Ventrias Bioprocessing Facility
5. Advanced Analytical Technologies, Inc. Expands Into New Office and Production Space
6. MedImmune Expands R&D Capacity with New Research Facility in Cambridge, U.K.
7. SAFC Hitech(TM) Expands Electronic Materials Portfolio With the Introduction of Scintillation Crystal Growth Halides
8. American Red Cross Expands Agreement for Strategic Blood Management(TM) Services from Strategic Healthcare Group LLC
9. L&M Healthcare Communications LLC Expands Client Services With Executive Team Expansion
10. MRI Expands Energy Role: Launches Center for Integrated Algal Research and Creates Director of Energy Programs Position
11. Facet Solutions Establishes Corporate Headquarters and Expands Executive Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and ... and the 6000i models are higher end machines that use the more unconventional z-dimension ... light beam from the bottom of the cuvette holder. , FireflySci has developed ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
Breaking Biology Technology:
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
Breaking Biology News(10 mins):